Beam Therapeutics Inc logo

Beam Therapeutics Inc

2
NAS:BEAM (USA)  
$ 24.09 +0.41 (+1.73%) 12:53 PM EST
At Loss
P/B:
2.16
Volume:
234.88K
Avg Vol (2M):
1.37M
Also Trade In:
Volume:
234.88K
At Loss
Avg Vol (2M):
1.37M

Business Description

Beam Therapeutics Inc logo
Beam Therapeutics Inc
NAICS : 325411 SIC : 2833
ISIN : US07373V1052
Description
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
Name Current Vs Industry Vs History
Cash-To-Debt 6.51
Equity-to-Asset 0.67
Debt-to-Equity 0.18
Debt-to-EBITDA -1.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.12
Distress
Grey
Safe
Beneish M-Score 0.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.97
9-Day RSI 45.96
14-Day RSI 45.06
6-1 Month Momentum % -22.88
12-1 Month Momentum % -31.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.99
Quick Ratio 5.99
Cash Ratio 5.85

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.6
Shareholder Yield % -8.65

Financials (Next Earnings Date:2024-08-08 Est.)

BEAM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BEAM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Beam Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 360.911
EPS (TTM) ($) -1.78
Beta 2.15
Volatility % 89.68
14-Day RSI 45.06
14-Day ATR ($) 1.416628
20-Day SMA ($) 23.502
12-1 Month Momentum % -31.88
52-Week Range ($) 16.95 - 49.5
Shares Outstanding (Mil) 82.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Beam Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Beam Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Beam Therapeutics Inc Frequently Asked Questions

What is Beam Therapeutics Inc(BEAM)'s stock price today?
The current price of BEAM is $24.09. The 52 week high of BEAM is $49.50 and 52 week low is $16.95.
When is next earnings date of Beam Therapeutics Inc(BEAM)?
The next earnings date of Beam Therapeutics Inc(BEAM) is 2024-08-08 Est..
Does Beam Therapeutics Inc(BEAM) pay dividends? If so, how much?
Beam Therapeutics Inc(BEAM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1